Application of MET pharmacodynamic assays to compare effectiveness of five MET inhibitors to engage target in tumor tissue.

11103 Background: Several MET inhibitors are currently being developed that block aberrant HGF/MET signaling in different cancers. We utilized validated MET pharmacodynamic (PD) assays to compare t...